Metabolomic analysis and signatures in motor neuron disease
- 1 April 2005
- journal article
- research article
- Published by Springer Nature in Metabolomics
- Vol. 1 (2) , 101-108
- https://doi.org/10.1007/s11306-005-4810-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The role of analytical sciences in medical systems biologyCurrent Opinion in Chemical Biology, 2004
- Metabolomics and systems biology: making sense of the soupCurrent Opinion in Microbiology, 2004
- Understanding 'Global' Systems Biology: Metabonomics and the Continuum of MetabolismNature Reviews Drug Discovery, 2003
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic deathNature Genetics, 2003
- Mutant dynactin in motor neuron diseaseNature Genetics, 2003
- Presence of 4‐hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosisAnnals of Neurology, 1998
- Increased 3‐nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosisAnnals of Neurology, 1997
- A Controlled Trial of Riluzole in Amyotrophic Lateral SclerosisNew England Journal of Medicine, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- RISING MORTALITY FROM MOTONEURON DISEASE IN THE USA, 1962-84The Lancet, 1989